Predicting drug-induced cholestasis: preclinical models-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predicting drug-induced cholestasis: preclinical models

Published:2018-06-20 Issue:7 Volume:14 Page:721-738
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Petrov Petar D.¹²^ORCID,Fernández-Murga M. Leonor¹^ORCID,López-Riera Mireia¹,Goméz-Lechón M. José¹²,Castell Jose V.¹²³^ORCID,Jover Ramiro¹²³^ORCID

Affiliation:

1. Instituto de Investigación Sanitaria La Fe (IIS La Fe), Unidad de Hepatología Experimental, Valencia, Spain

2. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain

3. Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Universidad de Valencia, Valencia, Spain

Funder

Hecatos EU Research Project

Instituto de Salud Carlos III (Spanish Ministry of Economy and Competitiveness)‐FEDER (EU) fund

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2018.1487399

Reference151 articles.

1. Case Definition and Phenotype Standardization in Drug-Induced Liver Injury

2. Phenotypic characterization of idiosyncratic drug-induced liver injury: The influence of age and sex

3. Incidence, Presentation, and Outcomes in Patients With Drug-Induced Liver Injury in the General Population of Iceland

4. Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kuhuang injection exerts a protective effect by activating PPAR-γ in an in vitro model of chlorpromazine-induced cholestatic liver injury constructed by tissue engineering;Pharmaceutical Biology;2022-09-05

2. Introducing CELLBLOKS®: a novel organ-on-a-chip platform allowing a plug-and-play approach towards building organotypic models;In vitro models;2022-07-04

3. Introducing CELLBLOKS^®: a novel organ-on-a-chip platform allowing a plug-and-play approach towards building organotypic models;2022-04-06

4. Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction;Acta Pharmaceutica Sinica B;2021-12

5. A Model‐Based Workflow to Benchmark the Clinical Cholestasis Risk of Drugs;Clinical Pharmacology & Therapeutics;2021-09-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3